Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:50 AM
Ignite Modification Date:
2025-12-25 @ 2:50 AM
NCT ID:
NCT02176733
Eligibility Criteria:
Inclusion Criteria:
* patient with the mutation confirmed by molecular analysis
* patient with a recent loss of monocular vision (≤ 6 months)
* voluntarily Patient Consent
Exclusion Criteria:
* patient who have not given their written and informed consent signed
* against indication of cyclosporine
* no drug compliance to previous inclusion
* no national health insurance affiliation
* pregnant women or lactating
* women who could become pregnant during the study period and with no contraception
* private patients of their liberty by judicial or administrative decision, or patients under supervision
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02176733
Study Brief:
Protocol Section:
NCT02176733